ClinicalTrials.gg
RecruitingNCT07089953Updated Oct 19, 2026

Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

An interventional study of Questionnaire and Video in Communication Skills, Professionalism and Randomized Controlled Trial, sponsored by M.D. Anderson Cancer Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by M.D. Anderson Cancer Center · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 370 studies in Communication with a site in United States — 74 open to participants now, 93 under way, 3 of them phase 3. Communication · United States.

Planned enrollment
209th of 320
88 · median 166
Started
2026
with 26 others
No phase
296 of 370
61 open now
Primary completion
2026-12
later than 22 of 92 live
Registered
329th of 370
by date

Among the 370 studies in Communication with a site in United States, this one is the 209th largest by planned enrollment of the 320 interventional ones that give a count, is one of 27 that started in 2026, is one of 296 with no phase, reaches primary completion later than 22 of the 92 other live ones, and was the 329th registered.

Communication

720 studies on the registry are indexed under Communication; 160 are open to participants now.

Browse Communication studies →

Open to participants now

74 of the 370 studies in Communication with a site in United States are open now. Recruiting first, the newest first:

68 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 88 Communication studies recruiting now, 53 (60%) set no upper age limit and 28 (32%) stop at 75 or younger; 32 take children under 18; 34 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 370 studies in Communication with a site in United States, or all of them as a file.
02

Study summary

To learn about how patients view a doctor's compassion, communication skills, and professionalism based on whether the doctor uses the Electronic Health Record (EHR) during a visit with a patient.

Read the detailed description

Primary Objectives 1. To compare participants' perception of physicians' compassion after they watch two scripted-video vignettes of physicians: one portraying a traditional face to face clinical visit without the use of examination room computer, and the other one portraying a physician using an integrated model of EHR use for communication during the visit.

Secondary Objectives

1. Study To compare participants' perception of physicians' communication skills after they watch two scripted-video vignettes of physicians: one portraying a traditional face to face clinical visit without examination room computer use, and the other one portraying a physician using an integrated model of EHR use during communication.

03

Conditions studied

  • Communication Skills
  • Professionalism
  • Randomized Controlled Trial
  • Perception

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Eligibility Criteria

  1. Participants with a diagnosis of cancer either early disease or advanced cancer defined as locally advanced, recurrent, or disease.
  2. Outparticipants (either new referrals or follow-ups) seen in the Supportive Care Clinic.
  3. Age >/= 18 years old.
  4. Able to read, write, and speak English.
  5. Participants with normal cognitive status (Memorial Delirium Assessment Scale (MDAS) \</= 6/30) who can understand the nature and purpose of the study and have the ability to complete the consent process.

Exclusion Criteria

  1. Participants who are experiencing severe symptom distress, including severe emotional distress, which may interfere with study participation. This will be measured by the Edmonton Symptom Assessment Scale (ESAS). Eligibility of participants with ESAS score >/= 7 on any item will be determined by the principal investigator and/or attending physician who is caring for the patient during that visit.
  2. Participants with cognitive dysfunction (Memorial Delirium Assessment Scale (MDAS) >/= 7/30 will be excluded from the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Care provider)
Enrollment
88 participants (estimated)

Study arms

  • Other
    Arm 1

    Physician A - No EHR

    Other: Questionnaire · Other: Video

  • Other
    Arm 2

    Physician B - No EHR

    Other: Questionnaire · Other: Video

  • Other
    Arm 3

    Physician A - Prime EHR

    Other: Questionnaire · Other: Video

  • Other
    Arm 4

    Physician B - Prime EHR

    Other: Questionnaire · Other: Video

Interventions

  • OtherQuestionnaire

    Complete 3 questionnaires about your emotions and your trust in doctors.

    Also known as: Questionnaires/Survey Measures

  • OtherVideo

    Four (4) videos, each 4 minutes long, have been made for use in this study.

06

What researchers measure

Primary outcomes

  1. Questionnaires/Videos

    Time frame: Through study completion; an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 389 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's planned 4 months is below that.

Counting every sponsor, half of 393 studies reached it within 18 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2025
First posted
Jul 29, 2025
StartActual
Aug 3, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2028
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07089953
Responsible party
Sponsor
First posted
Jul 29, 2025
Start date
Aug 3, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 19, 2026

Study contacts

Ali Haider, MD
Contact
ahaider@mdanderson.org
713-563-9844
Ali Haider, MD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion